Title : Deferoxamine reduces tissue injury and lethality in LPS-treated mice.

Pub. Date : 2000 Aug

PMID : 10988358






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In vivo studies demonstrated that pretreatment of mice with DFX reduces tumor necrosis factor alpha (TNF-alpha) serum levels and increases the rate of survival of mice inoculated with lethal doses of lipopolysaccharide (LPS) or Escherichia coli O111:B4. Deferoxamine tumor necrosis factor Mus musculus
2 In vivo studies demonstrated that pretreatment of mice with DFX reduces tumor necrosis factor alpha (TNF-alpha) serum levels and increases the rate of survival of mice inoculated with lethal doses of lipopolysaccharide (LPS) or Escherichia coli O111:B4. Deferoxamine tumor necrosis factor Mus musculus
3 On the other hand, DFX prevents mortality induced either by LPS or murine recombinant TNF-alpha in D(+)-galactosamine (GalN)-sensitized mice. Deferoxamine tumor necrosis factor Mus musculus
4 These protective actions of DFX correlate with an attenuated tissue damage observed in lungs, livers and kidneys of LPS-treated animals and GalN-sensitized mice inoculated with TNF-alpha. Deferoxamine tumor necrosis factor Mus musculus